News
Moderna also hopes that combining the shots will help improve vaccine rates. Poland, however, is not sure people will like ...
A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...
The Cambridge-based company says the vaccine is at least as good as getting both vaccines separately, it will seek FDA ...
In a study published in the Journal of the American Medical Association, researchers from Moderna reported that the new combo ...
MM+M Women of Distinction honoree, announced Monday morning that she has joined Medtronic Diabetes as its chief marketing ...
Moderna is being audited by the PMCPA after yet again being found to have brought discredit on the pharma industry, putting the company on a path that could lead to its suspension from U. | Moderna is ...
Moderna’s combined Covid and flu shot outperformed the existing standalone vaccines for both viruses, according to the ...
Moderna's study, involving 8,000 adults 50 and older, showed the new combo shot generated an immune response against COVID ...
Biotechnology company Moderna (NASDAQ:MRNA) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 35.3% year on year to $108 million. The company’s full-year revenue ...
Moderna could face suspension from Britain’s pharmaceutical trade body following a string of breaches of the regulatory code. The Covid vaccine maker is due to be audited by the Prescription ...
CAMBRIDGE, MA / ACCESS Newswire / May 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today reported financial results and provided business updates for the first quarter of 2025. "In the first quarter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results